Amneal Pharmaceuticals, Inc.AMRXNASDAQ
LOADING
|||
EPS Growth Under Pressure
Trending lower, above historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
20.83%
↑ 113% above average
Average (9y)
-162.27%
Historical baseline
Range
High:113.57%
Low:-1328.57%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| 2024 | 20.83% |
| 2023 | 44.19% |
| 2022 | -1328.57% |
| 2021 | -88.71% |
| 2020 | 113.57% |
| 2019 | -243.61% |
| 2018 | -191.10% |
| 2017 | 32.73% |
| 2016 | 22.22% |
| 2015 | -4.26% |